And when Classiq recently asked more than 500 professionals across sectors whether their organizations are currently patenting or have plans to patent quantum software-related IP, 71% said yes.

Source: https://www.forbes.com/sites/forbestechcouncil/2023/01/17/how-to-create-and-protect-quantum-intellectual-property-to-maintain-your-competitive-edge/

However, the argument for patenting is that if it's not patented, then these companies aren't not going to invest the money to get it trialed, to turn it into a usual drug, to work out exactly what therapy needs to go with it, to make it safe.

Source: https://seekingalpha.com/article/4570075-psychedelic-sunday-competitive-strategies?source=feed_all_articles